Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-01-13 | Amended | $23,022,065 | $15,330,232 | Other | 06b | SEC link |
| 2023-12-22 | New | $7,691,833 | $7,691,833 | Other | 06b | SEC link |
| 2021-12-02 | New | $92,209,653 | $92,209,653 | Equity Only | 06b | SEC link |
| 2021-05-06 | New | $28,434,938 | $28,434,938 | Equity and Debt | 06b | SEC link |
| 2020-01-27 | New | $4,750,000 | $4,750,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Christian Angermayer | Director |
| Christian Angermeyer | Director |
| Paul Farr | Director |
| James G. Peyer | Director, Executive |
| Maryanna Saenko | Director |
| Brenton Saunders | Director |